Back to search
APDS Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which APDS Gene Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which APDS Gene Mutation trials you may qualify forThis study is designed to provide long-term CDZ173 treatment, a selective PI3Kδ inhibitor, to the patients with genetically activated PI3Kδ, i.e., patients with…
An Open-Label, Non-Randomized Study to Assess the Safety and Efficacy of Leniolisib in Japanese Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome…
This study was designed to explore CDZ173, a selective PI3Kδ inhibitor, in patients with genetically activated PI3Kδ, i.e., patients with Activated phosphoinosi…